STOCK TITAN

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

Mdxhealth (NASDAQ: MDXH) will release its first-quarter 2026 financial results for the period ended March 31, 2026, after market close on May 13, 2026.

(Neutral)
(Neutral)
Tags
earnings date

Mdxhealth (NASDAQ: MDXH) will release its first-quarter 2026 financial results for the period ended March 31, 2026, after market close on May 13, 2026. The company will host a conference call and live Q&A the same day at 4:30pm ET / 22:30 CET (Conference ID: MDX1Q26).

Investors may join via dial-in numbers for the US, Belgium, and UK or watch the webcast at the provided URL; the webcast replay will be available on the company website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus May 1 session
+0.98% close to close Open Argus
Details

News Market Reaction – MDXH

On May 1, the first trading day after this news, MDXH closed 0.98% above the previous close.

Data tracked by StockTitan Argus for the May 1 session.

Market Context

This announcement schedules MDxHealth’s Q1 2026 results for May 13, 2026 at 4:30pm ET, giving invest...
Analysis

This announcement schedules MDxHealth’s Q1 2026 results for May 13, 2026 at 4:30pm ET, giving investors a clear timing marker for the next financial update. Recent history includes preliminary revenue releases, full-year 2025 earnings, and multiple clinical data milestones, all of which shaped the story at a share price of $1.97, far below the $5.33 52-week high. Investors may focus on revenue growth, profitability trends, and any updated guidance once detailed figures are released.

Key Figures

Q1 2026 period end: March 31, 2026 Earnings release date: May 13, 2026 Conference time (ET): 4:30pm ET +2 more
Q1 2026 period end
March 31, 2026
Quarter to be reported
Earnings release date
May 13, 2026
Q1 2026 financial results after market close
Conference time (ET)
4:30pm ET
Q1 2026 results call start time
Conference time (CET)
22:30 CET
Q1 2026 results call start time
Webcast access lead
15 minutes
Recommended time before call start to access webcast

Historical Context

5 past events · Latest: Mar 16
5 events
  1. Mar 16

    Clinical data update

    24h Move
    -0.3%

    New Oxford ProMPT study data showing GPS test predicts prostate cancer outcomes.

  2. Feb 26

    Earnings release

    24h Move
    -4.2%

    Q4 and 2025 results with revenue growth, strong gross margin and improved EBITDA.

  3. Feb 12

    Earnings date set

    24h Move
    -0.6%

    Announcement of date and time for Q4 and full-year 2025 results call.

  4. Jan 12

    Prelim results/guidance

    24h Move
    +5.2%

    Preliminary Q4 and 2025 revenues, 2026 guidance and amended Exact Sciences earnout.

  5. Jan 06

    Clinical collaboration

    24h Move
    -3.0%

    Oxford ProtecT GPS validation initiative in large randomized prostate cancer trial.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET / 22:30 CET

IRVINE, California – April 30, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 13, 2026.

Title:

Mdxhealth Presents First Quarter 2026 Financial Results and
Corporate Update Conference Call and Webcast
Date:May 13, 2026
Time:4:30pm ET/ 22:30 CET
Conference Call Dial-in Details:

United States: 1-800-245-3047
Belgium: 0800 72 519
United Kingdom: 0808 101 1183



Conference ID:        MDX1Q26
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1758088&tp_key=21da6e9d38

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.

About Mdxhealth

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:

info@mdxhealth.com

LifeSci Advisors (IR & PR)
John Fraunces, Managing Director
Tel: +1 917 355 2395
jfraunces@lifesciadvisors.com

Attachment


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Mdxhealth (MDXH) report Q1 2026 financial results?

Direct answer: Mdxhealth will release Q1 2026 results after market close on May 13, 2026.

Context: According to the company, the results cover the quarter ended March 31, 2026 and will be followed by a conference call the same day.

What time is the Mdxhealth (MDXH) conference call and how can I join?

Direct answer: The conference call is set for 4:30pm ET / 22:30 CET on May 13, 2026.

Context: According to the company, participants can join via listed dial-in numbers or access the live webcast at the provided webcast URL; arrive 15 minutes early.

Will there be a replay of the Mdxhealth (MDXH) Q1 2026 webcast?

Direct answer: Yes. A replay of the webcast will be available after the live call on the company website.

Context: According to the company, the live webcast will be accessible at the listed URL and a recording will remain posted for later viewing following the event.

Which dial-in numbers can I use to join the Mdxhealth (MDXH) May 13, 2026 call?

Direct answer: Dial-in numbers include a US toll-free line and regional numbers for Belgium and the United Kingdom.

Context: According to the company, the announcement lists US: 1-800-245-3047, Belgium: 0800 72 519, and UK: 0808 101 1183 for the call.

Keep reading